Drug Tariff Shockwaves: How Trump’s 100% Pharma Levy Reshapes Global Medicine Supply Chains
Trump administration readies pharmaceutical tariff announcement with 100% duties on drugmakers. Global supply chains face disruption as Pfizer, AstraZeneca secure exemptions.





